Drug opportunities in Russia: navigating a fast changing marketplace
This article was originally published in SRA
Executive Summary
Inna Demidova discusses current and upcoming regulatory requirements for pharmaceutical companies operating in Russia and evaluates potential market access strategies for those looking to enter, expand or build momentum in what is one of the world’s fastest growing pharmaceutical markets.